Trump administration prepares new dietary guidelines for January rollout, launching major food policy overhaul in 2026 to ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...
Aldeyra ’s Reproxalap is the core catalyst. The FDA will make its decision on this asset by March 16, 2026, after a ...
MedPage Today on MSN
Five Leaders in One Year: FDA's Drug Center Enters 2026 at a Crossroads
The FDA appointed George Tidmarsh, MD, PhD, to be the nation's top drug official in July. The Center for Drug Evaluation and ...
11don MSN
Inside the FDA's vaccine uproar
A memo from Dr. Vinay Prasad, the head of the FDA's Center for Biologics Evaluation and Research, may signal an effort to to ...
FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
The research is part of the FDA’s Total Diet Study, which monitors levels of nutrients and contaminants in food.
Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...
Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...
The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...
Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with the birth control shot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results